Lance Willsey - 12 May 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 May 2022, 20:10:15 UTC
Prior SEC filing
28 May 2021
Next SEC filing
27 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher J. Senner, Attorney in Fact

Key filing fact

Lance Willsey filed Form 4 for EXELIXIS, INC. (EXEL) on 13 May 2022.

Key facts

  • This page summarizes Lance Willsey's Form 4 filing for EXELIXIS, INC. (EXEL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 May 2022, 20:10.

Change

  • Previous filing in this sequence was filed on 28 May 2021.
  • Current net transaction value: -$660,800.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Options Exercise

Transaction value
$125,200
Shares
+40,000
Change %
+9.4%
Price
$3.13*
Shares after
464,415
Date
12 May 2022
Ownership
Direct
EXEL transaction

Common Stock

Sale

Transaction value
$786,000
Shares
-40,000
Change %
-8.6%
Price
$19.65
Shares after
424,415
Date
12 May 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXEL transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-40,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
12 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$3.13
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.47 to $19.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

Footnote F2

The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .